HF
VCYT icon

HRT Financial’s Veracyte VCYT Stock Holding History

HRT Financial’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-31,312
Closed -$1.01M – 5420
2026
Q1 		$1.01M Buy
+31,312
New +$1.16M ﹤0.01% 2047
2025
Q1 		– Sell
-5,059
Closed -$200K – 3450
2024
Q4 		$200K Buy
+5,059
New +$192K ﹤0.01% 1939
2023
Q2 		– Sell
-56,136
Closed -$1.25M – 3329
2023
Q1 		$1.25M Sell
56,136
-32,991
-37% -$797K 0.02% 834
2022
Q4 		$2.11M Buy
89,127
+61,002
+217% +$1.42M 0.03% 564
2022
Q3 		$466K Buy
+28,125
New +$633K 0.01% 1670

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

HRT Financial's VCYT Position: Q2 2026 in Review

HRT Financial sold out of Veracyte (VCYT) in Q2 2026, closing a stake of 31,312 shares — an estimated $1.01M sold.

HRT Financial first reported a position in VCYT in Q3 2022 and held it in 5 quarters. The position peaked at $2.11M in Q4 2022. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • HRT Financial reported no remaining Veracyte position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 31,312 Veracyte shares in Q2 2026, an estimated $1.01M.
  • HRT Financial first reported a position in Veracyte in Q3 2022 and held it in 5 quarters.
  • HRT Financial's Veracyte position peaked at $2.11M in Q4 2022.
  • 371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.